Eyepoint Pharmaceuticals Inc (EYPT) — Financial Flexibility Index
Eyepoint Pharmaceuticals Inc (EYPT) has a Financial Flexibility Index of -1.14x as of September 2025. Free cash flow of $-58.56 Million (operating CF $-59.35 Million minus capex $798.00K) represents -1% of total liabilities ($51.51 Million). Check total reinvestment intensity of Eyepoint Pharmaceuticals Inc to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Eyepoint Pharmaceuticals Inc Financial Flexibility Index (2002–2024)
Historical Financial Flexibility Index trend for Eyepoint Pharmaceuticals Inc across 23 annual periods. For the full cash flow conversion analysis, see Eyepoint Pharmaceuticals Inc cash flow conversion.
Annual Financial Flexibility Index for Eyepoint Pharmaceuticals Inc (2002–2024)
Year-by-year free cash flow to debt coverage for Eyepoint Pharmaceuticals Inc. Explore how well can Eyepoint Pharmaceuticals Inc service its debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.49x | $-122.17 Million | $-126.23 Million | $81.96 Million | ▼ -2572.1% |
| 2023 | 0.06x | $5.36 Million | $1.88 Million | $88.86 Million | ▲ +108.1% |
| 2022 | -0.75x | $-62.85 Million | $-65.00 Million | $83.99 Million | ▼ -18.4% |
| 2021 | -0.63x | $-49.94 Million | $-50.10 Million | $78.99 Million | ▼ -228.7% |
| 2020 | -0.19x | $-14.07 Million | $-14.44 Million | $73.18 Million | ▲ +78.0% |
| 2019 | -0.87x | $-56.49 Million | $-56.70 Million | $64.64 Million | ▼ -140.4% |
| 2018 | -0.36x | $-21.80 Million | $-21.91 Million | $59.98 Million | ▲ +90.5% |
| 2017 | -3.81x | $-20.34 Million | $-20.49 Million | $5.34 Million | ▼ -152.4% |
| 2016 | -1.51x | $-16.20 Million | $-16.32 Million | $10.74 Million | ▼ -229.8% |
| 2015 | 1.16x | $10.46 Million | $10.30 Million | $9.00 Million | ▲ +186.4% |
| 2014 | -1.35x | $-10.42 Million | $-10.67 Million | $7.75 Million | ▼ -32.6% |
| 2013 | -1.01x | $-8.68 Million | $-8.74 Million | $8.55 Million | ▲ +17.8% |
| 2012 | -1.23x | $-8.60 Million | $-9.00 Million | $6.96 Million | ▼ -293.6% |
| 2011 | -0.31x | $-3.04 Million | $-3.17 Million | $9.68 Million | ▼ -131.6% |
| 2010 | 0.99x | $9.91 Million | $9.90 Million | $9.97 Million | ▲ +263.6% |
| 2009 | -0.61x | $-8.24 Million | $-8.44 Million | $13.56 Million | ▼ -117.5% |
| 2008 | -0.28x | $-4.87 Million | $-5.14 Million | $17.44 Million | ▲ +73.3% |
| 2007 | -1.05x | $-21.13 Million | $-21.21 Million | $20.21 Million | ▼ -119.1% |
| 2006 | -0.48x | $-14.98 Million | $-16.14 Million | $31.40 Million | ▲ +89.0% |
| 2005 | -4.34x | $-6.75 Million | $-9.34 Million | $1.56 Million | ▲ +0.0% |
| 2004 | -4.34x | $-6.75 Million | $-9.34 Million | $1.56 Million | ▼ -15.4% |
| 2003 | -3.76x | $-5.07 Million | $-5.44 Million | $1.35 Million | ▲ +26.8% |
| 2002 | -5.14x | $-3.02 Million | $-3.06 Million | $588.38K | — |